Teacher Retirement System of Texas Acquires New Shares in Cellebrite DI Ltd. (NASDAQ:CLBT)

Teacher Retirement System of Texas bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 20,070 shares of the company’s stock, valued at approximately $442,000.

A number of other large investors have also recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its holdings in Cellebrite DI by 21.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 427,655 shares of the company’s stock worth $7,202,000 after purchasing an additional 75,092 shares in the last quarter. Two Sigma Advisers LP lifted its holdings in shares of Cellebrite DI by 9.8% in the third quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company’s stock worth $22,584,000 after buying an additional 120,000 shares in the last quarter. Harbor Capital Advisors Inc. boosted its position in shares of Cellebrite DI by 65.4% in the fourth quarter. Harbor Capital Advisors Inc. now owns 157,671 shares of the company’s stock valued at $3,473,000 after acquiring an additional 62,320 shares during the period. State Street Corp boosted its position in shares of Cellebrite DI by 7.3% in the third quarter. State Street Corp now owns 443,700 shares of the company’s stock valued at $7,472,000 after acquiring an additional 30,052 shares during the period. Finally, New York State Common Retirement Fund grew its stake in Cellebrite DI by 2.6% during the fourth quarter. New York State Common Retirement Fund now owns 189,599 shares of the company’s stock valued at $4,177,000 after acquiring an additional 4,838 shares in the last quarter. 45.88% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on CLBT. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 target price on shares of Cellebrite DI in a research note on Thursday, March 27th. Lake Street Capital lifted their price objective on Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, February 14th. Finally, JPMorgan Chase & Co. upped their target price on Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Seven research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI currently has a consensus rating of “Buy” and an average price target of $23.43.

Cellebrite DI Stock Down 0.2 %

NASDAQ CLBT opened at $19.43 on Tuesday. The stock’s 50-day simple moving average is $20.78 and its two-hundred day simple moving average is $19.93. Cellebrite DI Ltd. has a twelve month low of $10.25 and a twelve month high of $26.30. The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of -13.98, a PEG ratio of 4.27 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. On average, equities analysts expect that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.